For this purpose, cells were enriched, and the CTC fraction was labelled by immunofluorescence staining with specific antibodies against well-established marker antigens of CRC cells—pan-CK, EpCAM, EGFR and Her2. This evidence concerns the gene EPCAM and colorectal carcinoma.